Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 182

    1.

    CD4(+)CD25(+) T-cells control autoimmunity in the absence of B-cells.

    Mariño E, Villanueva J, Walters S, Liuwantara D, Mackay F, Grey ST.

    Diabetes. 2009 Jul;58(7):1568-77. Epub 2009 Mar 31.PMID: 19336675 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.

    Mukherjee R, Chaturvedi P, Qin HY, Singh B.

    J Autoimmun. 2003 Nov;21(3):221-37.PMID: 14599847 [PubMed - indexed for MEDLINE]Related articles

    3.

    CD3 antibody treatment stimulates the functional capability of regulatory T cells.

    Chatenoud L.

    Novartis Found Symp. 2003;252:279-86; discussion 286-90. Review.PMID: 14609225 [PubMed - indexed for MEDLINE]Related articles

    4.

    All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.

    Van YH, Lee WH, Ortiz S, Lee MH, Qin HJ, Liu CP.

    Diabetes. 2009 Jan;58(1):146-55. Epub 2008 Nov 4.PMID: 18984738 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    APC activation restores functional CD4(+)CD25(+) regulatory T cells in NOD mice that can prevent diabetes development.

    Manirarora JN, Kosiewicz MM, Parnell SA, Alard P.

    PLoS One. 2008;3(11):e3739. Epub 2008 Nov 17.PMID: 19011680 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cells.

    Harnaha J, Machen J, Wright M, Lakomy R, Styche A, Trucco M, Makaroun S, Giannoukakis N.

    Diabetes. 2006 Jan;55(1):158-70.PMID: 16380489 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.

    Gregori S, Giarratana N, Smiroldo S, Adorini L.

    J Immunol. 2003 Oct 15;171(8):4040-7.PMID: 14530324 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.

    Alard P, Manirarora JN, Parnell SA, Hudkins JL, Clark SL, Kosiewicz MM.

    Diabetes. 2006 Jul;55(7):2098-105.PMID: 16804081 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells.

    Mellanby RJ, Thomas D, Phillips JM, Cooke A.

    Immunology. 2007 May;121(1):15-28.PMID: 17428252 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Human chorionic gonadotropin is an immune modulator and can prevent autoimmune diabetes in NOD mice.

    Khil LY, Jun HS, Kwon H, Yoo JK, Kim S, Notkins AL, Yoon JW.

    Diabetologia. 2007 Oct;50(10):2147-55. Epub 2007 Aug 4.PMID: 17676307 [PubMed - indexed for MEDLINE]Related articles

    12.

    Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells.

    Ly D, Mi QS, Hussain S, Delovitch TL.

    J Immunol. 2006 Sep 15;177(6):3695-704.PMID: 16951329 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.

    Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD, Sutherland DE, Hering BJ, Guo Z.

    Transplantation. 2009 Jan 27;87(2):198-206.PMID: 19155973 [PubMed - indexed for MEDLINE]Related articles

    15.

    Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes.

    Waid DM, Vaitaitis GM, Pennock ND, Wagner DH Jr.

    J Leukoc Biol. 2008 Aug;84(2):431-9. Epub 2008 May 9.PMID: 18469093 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    IL-10 impacts autoimmune diabetes via a CD8+ T cell pathway circumventing the requirement for CD4+ T and B lymphocytes.

    Balasa B, Davies JD, Lee J, Good A, Yeung BT, Sarvetnick N.

    J Immunol. 1998 Oct 15;161(8):4420-7.PMID: 9780221 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.

    He F, Chen Z, Xu S, Cai M, Wu M, Li H, Chen X.

    Surgery. 2009 Jun;145(6):663-74. Epub 2009 Apr 19.PMID: 19486771 [PubMed - indexed for MEDLINE]Related articles

    18.

    Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.

    Day ES, Cachero TG, Qian F, Sun Y, Wen D, Pelletier M, Hsu YM, Whitty A.

    Biochemistry. 2005 Feb 15;44(6):1919-31.PMID: 15697217 [PubMed - indexed for MEDLINE]Related articles

    19.

    Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.

    Tarbell KV, Petit L, Zuo X, Toy P, Luo X, Mqadmi A, Yang H, Suthanthiran M, Mojsov S, Steinman RM.

    J Exp Med. 2007 Jan 22;204(1):191-201. Epub 2007 Jan 8.PMID: 17210729 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The B-subunit of cholera toxin induces immunoregulatory cells and prevents diabetes in the NOD mouse.

    Sobel DO, Yankelevich B, Goyal D, Nelson D, Mazumder A.

    Diabetes. 1998 Feb;47(2):186-91.PMID: 9519711 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data